NCT05547659

Brief Summary

Many surgical procedures are accompanied by postoperative pain with severity moderate, severe or extreme and insufficient postoperative pain control may cause risk of post-surgical complications and risk of chronic post-surgical pain The targets of preoperative pain management are to relieve patient suffering, reduce length of hospital stay and achieve early mobilization after surgery, decreasing opioid consumption and its side effects that are constipation, nausea, vomiting, dizziness, respiratory depression which is the most feared complication being life-threatening and some less common side effects as sedation

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

August 25, 2022

Completed
27 days until next milestone

First Posted

Study publicly available on registry

September 21, 2022

Completed
Last Updated

September 21, 2022

Status Verified

September 1, 2022

Enrollment Period

1.2 years

First QC Date

August 25, 2022

Last Update Submit

September 19, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Postoperative visual analogue scale (VAS)

    The visual analog scale (VAS) is a simple and often used method for evaluating variations in pain intensity.

    24 hour postoperative

  • Amount of post operative Needed opioid analgesia

    ampules of opioid analgesia needed after operation

    24 hour postoperative

Secondary Outcomes (1)

  • Type and amount of prescribed post operative non opioid analgesia

    24 hour postoperative

Other Outcomes (1)

  • Reported opioid side effects

    24 hour postoperative

Study Arms (3)

multimodal

ACTIVE COMPARATOR

pregabalin/ acetaminophen/ celecoxib

Drug: Pregabalin 150mgDrug: Acetaminophen 1 G Oral TabletDrug: Celecoxib 400Mg Oral Capsule

unimodal

ACTIVE COMPARATOR

Pregabalin

Drug: Pregabalin 150mg

control

NO INTERVENTION

Interventions

Pregabalin 150mg preoperative in unimodal group Pregabalin 150mg preoperative in multi-modal group

multimodalunimodal

Acetaminophen 1 G Oral Tablet preoperative in multi-modal group

multimodal

Celecoxib 400Mg Oral Capsule preoperative in multi-modal group

multimodal

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients undergoing laparoscopic cholecystectomy
  • Patients older than 18 years old

You may not qualify if:

  • Renal or hepatic or cardiac impairment patients
  • Patients with chronic pain history
  • Allergic patients after taking aspirin or other NSAIDs
  • patients with active gastrointestinal bleeding, ulcer and inflammatory bowel diseases or cerebrovascular bleeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Beni suef University hospital

Banī Suwayf, Egypt

Location

Beni-Suef Hospital

Banī Suwayf, Egypt

Location

MeSH Terms

Interventions

PregabalinAcetaminophenTabletsCelecoxib

Intervention Hierarchy (Ancestors)

gamma-Aminobutyric AcidAminobutyratesButyratesAcids, AcyclicCarboxylic AcidsOrganic ChemicalsAmino AcidsAmino Acids, Peptides, and ProteinsAcetanilidesAnilidesAmidesAniline CompoundsAminesDosage FormsPharmaceutical PreparationsBenzenesulfonamidesSulfonamidesBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsSulfonesSulfur CompoundsPyrazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
head of clinical pharmacy unit

Study Record Dates

First Submitted

August 25, 2022

First Posted

September 21, 2022

Study Start

January 1, 2019

Primary Completion

April 1, 2020

Study Completion

December 1, 2020

Last Updated

September 21, 2022

Record last verified: 2022-09

Locations